Since receiving backing from Nordic Capital and Avista Capital Partners in August 2008 to create an independent enterprise, ConvaTec continues to accelerate its commitment to expand its broad array of products and customer solutions developed from rigorous science and borne from our collaboration with healthcare professionals and end-users.
Founded in 1989, Nordic Capital is a group of private equity funds that seek to create long-term value in their investments through committed ownership and by strategic development and operational improvements. One of the private equity pioneers in northern Europe, Nordic Capital invests in medium and large-sized companies in the Nordic region and pursues select investment opportunities internationally.
While Nordic Capital invests in all industries and sectors, healthcare is the one focus area in which the firm has gained substantial experience through a track-record of successful investments and a strong team. The disciplined investing process involves multiple deal sourcing channels, careful analysis, thorough due diligence and a clear post-acquisition plan. Nordic Capital's funds are advised through offices in Copenhagen, Frankfurt, Helsinki, London, Oslo and Stockholm.
Avista Capital Partners is a leading private equity firm managing approximately $4 billion of committed capital with offices in New York, Houston, and London. Founded in 2005, Avista's strategy is to make controlling or influential minority investments in growth-oriented energy, healthcare, media, industrial and consumer businesses. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses.